We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App





MEDICA 2021 + COMPAMED 2021 Far Exceed Expectations and Achieve Extremely Successful Results

By LabMedica International staff writers
Posted on 19 Nov 2021
Print article
Image: MEDICA 2021 + COMPAMED 2021 Far Exceed Expectations and Achieve Extremely Successful Results (Photo courtesy of medica-tradefair.com)
Image: MEDICA 2021 + COMPAMED 2021 Far Exceed Expectations and Achieve Extremely Successful Results (Photo courtesy of medica-tradefair.com)

After their four-day run as an in-person event, MEDICA and COMPAMED achieved extremely successful results in Düsseldorf, Germany.

From 15 to 18 November 2021, the world’s leading information and communication platforms for the medical technology industry and its supplier sector presented a wealth of convincing innovations as well as accompanying programs that covered a wide range of topics (supplemented by digital offers) and did justice to their internationally prestigious position. 46,000 visitors (with an international share of 73%) from 150 countries seized the opportunity to engage in person with the 3,033 MEDICA and 490 COMPAMED exhibitors in Düsseldorf, obtaining information on the comprehensive range of innovations for outpatient and inpatient care, including every step of their development and manufacture, and trying out many innovative products live in the trade fair halls.

The industry portals MEDICA.de and COMPAMED.de added a range of offers in line with the live events at the trade fairs. This allowed users to access livestreams to watch the stage programs of all expert forums that had been integrated into the trade fairs as well as the 44th German Hospital Conference and the MEDICA MEDICINE + SPORTS CONFERENCE; network via the special Matchmaking tool; and obtain information on innovative products in the exhibitors’ online showrooms.

As expected, COVID-19 and the findings gained to date while managing the pandemic with regard to the implementation of new therapeutic approaches and care concepts were recurring themes in many talks at the forums and accompanying conferences. The MEDICA MEDICINE + SPORTS CONFERENCE, for example, took a closer look at how to get back into sports after suffering from long COVID, while the MEDICA ECON FORUM and the MEDICA HEALTH IT FORUM focused on digitizing processes in the healthcare system.

In line with these themes, exhibitors offered many innovations for the clinical and outpatient field. And the young start-up scene was heavily involved as well, something that was impressively proven during the thrilling pitch competitions held as part of the 10th MEDICA Startup COMPETITION and the 13th Healthcare Innovation World Cup, which took place on the MEDICA CONNECTED HEALTHCARE FORUM program stage. The 13th Healthcare Innovation World Cup focused on innovative devices and smart applications for digital networking and process integration, with an eye to the Internet of Medical Things. From among 300 entries, the jury selected 12 start-ups for the finals on 15 November. Ideas ranged from artificial intelligence (AI) and health apps to robotics at the 10th MEDICA Startup COMPETITION (on 16 November).

Trends along the entire process chain of medical technological manufacture and product developments dominated both the trade fair business of exhibitors and visitors at COMPAMED (which took place in Halls 13 and 14 this time around) and the stage programs of the two integrated expert forums. Innovative substances played just as great a role as innovative, printed electronics, smart sensor solutions and microfluidic options to resolve challenges in point of care diagnostics.

“The atmosphere in the trade fair halls was relaxed and characterised by a sense of optimism throughout; conversations with our customers have shown that in many cases, we have exceeded expectations. People were finally able to establish new and intensify existing contacts in person,” said Erhard Wienkamp, Managing Director of Messe Düsseldorf.

“The numbers are encouraging, and were hardly expected to be at this level in spring. With the combination of trade fair events and digital supplements, MEDICA and COMPAMED have given the industry strong stimuli. The exhibitors are happy to have come to Düsseldorf and are already actively inquiring about options to take part next year,” added Christian Grosser, Director Health & Medical Technologies at Messe Düsseldorf, thus reflecting the positive signals fed back by participants and trade associations alike.

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics)

Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection

Patients with liver cirrhosis and chronic hepatitis B are at a higher risk for developing hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. The American Association for the Study... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical)

POC STI Test Shortens Time from ED Arrival to Test Results

In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.